Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Nukiwa, M. Xie, T. Fukuhara, C. Treda, T. Kikuchi, M. Ebina, T. Nukiwa (Sendai, Japan). Why is allograft formation in SCID mice slow in lung adenocarcinoma cell line with EGFR activating mutation?. Eur Respir J 2010; 36: Suppl. 54, 5168

Member's Comments

No comment yet.

Related content which might interest you: Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 Tiotropium inhibits growth of squamous cell lung carcinoma (SCC) cell lines in vitro and also inhibits SCC growth in vivo in nude mice by inhalation Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Effects of ASCL1 expression on tumorigenesis and immune cell infiltration in a syngenic mouse model of lung adenocarcinoma Source: International Congress 2019 – Biology of lung cancer Year: 2019 Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003 Increased proliferation of type 2 alveolar epithelial cells in a pneumonectomy model mice with a deletion of p16ink4a gene. Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Is caveolin-1 lost as a tumor suppressor gene in lung carcinoma? Source: Annual Congress 2004 - Lung development and cancer Year: 2004 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival Source: Eur Respir J 2009; 33: 118-126 Year: 2009 Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004 Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002 In vivo models of human airway epithelium repair and regeneration Source: Eur Respir Rev 2005; 14: 131-136 Year: 2005 Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007 MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 ADAM28 deletion in mice impacts lung metastasis formation Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018 Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 811s Year: 2006